Montecito Bank & Trust’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.73M Sell
21,223
-459
-2% -$53.7K 0.41% 58
2026
Q1
$2.61M Sell
21,682
-1,054
-5% -$122K 0.43% 52
2025
Q4
$2.39M Sell
22,736
-4,593
-17% -$431K 0.38% 60
2025
Q3
$2.29M Buy
+27,329
New +$2.25M 0.36% 64
2025
Q1
$2.69M Buy
29,916
+324
+1% +$30.3K 0.48% 48
2024
Q4
$2.94M Buy
29,592
+2,386
+9% +$246K 0.51% 47
2024
Q3
$3.09M Buy
27,206
+5,302
+24% +$630K 0.53% 46
2024
Q2
$2.71M Buy
21,904
+1,084
+5% +$140K 0.55% 41
2024
Q1
$2.75M Buy
20,820
+1,117
+6% +$138K 0.55% 41
2023
Q4
$2.15M Buy
19,703
+597
+3% +$62K 0.46% 50
2023
Q3
$1.97M Buy
19,106
+464
+2% +$50K 0.46% 51
2023
Q2
$2.15M Sell
18,642
-779
-4% -$88.4K 0.49% 46
2023
Q1
$2.07M Sell
19,421
-218
-1% -$23.5K 0.49% 48
2022
Q4
$2.18M Sell
19,639
-511
-3% -$52.2K 0.53% 50
2022
Q3
$1.74M Buy
20,150
+1,047
+5% +$93.5K 0.45% 54
2022
Q2
$1.74M Sell
19,103
-6
-0% -$532 0.41% 57
2022
Q1
$1.57M Sell
19,109
-387
-2% -$30.5K 0.29% 78
2021
Q4
$1.49M Sell
19,496
-151
-0.8% -$12K 0.26% 85
2021
Q3
$1.48M Buy
19,647
+47
+0.2% +$3.58K 0.29% 85
2021
Q2
$1.52M Sell
19,600
-332
-2% -$24.7K 0.29% 81
2021
Q1
$1.47M Buy
19,932
+1,279
+7% +$94.3K 0.3% 80
2020
Q4
$1.46M Sell
18,653
-39
-0.2% -$2.98K 0.32% 74
2020
Q3
$1.48M Buy
18,692
+159
+0.9% +$12.5K 0.38% 69
2020
Q2
$1.37M Buy
18,533
+460
+3% +$34.6K 0.38% 68
2020
Q1
$1.33M Buy
18,073
+4,223
+30% +$332K 0.43% 57
2019
Q4
$1.2M Buy
13,850
+2,683
+24% +$220K 0.32% 71
2019
Q3
$897K Buy
11,167
+209
+2% +$16.8K 0.27% 86
2019
Q2
$877K Sell
10,958
-392
-3% -$30K 0.26% 87
2019
Q1
$901K Hold
11,350
0.28% 86
2018
Q4
$828K Sell
11,350
-135
-1% -$9.53K 0.29% 81
2018
Q3
$777K Sell
11,485
-1,336
-10% -$85.1K 0.23% 91
2018
Q2
$743K Sell
12,821
-382
-3% -$21.6K 0.24% 83
2018
Q1
$686K Buy
13,203
+1,278
+11% +$69K 0.22% 81
2017
Q4
$640K Sell
11,925
-69
-0.6% -$3.83K 0.21% 80
2017
Q3
$732K Sell
11,994
-70
-0.6% -$4.24K 0.25% 67
2017
Q2
$737K Sell
12,064
-1,676
-12% -$102K 0.27% 67
2017
Q1
$833K Buy
13,740
+1,294
+10% +$78.5K 0.3% 62
2016
Q4
$699K Buy
12,446
+80
+0.6% +$4.68K 0.24% 77
2016
Q3
$737K Hold
12,366
0.3% 76
2016
Q2
$680K Buy
12,366
+869
+8% +$46.2K 0.29% 77
2016
Q1
$580K Sell
11,497
-214
-2% -$10.5K 0.26% 73
2015
Q4
$590K Buy
+11,711
New +$590K 0.28% 69
2014
Q2
Sell
-6,536
Closed -$354K 149
2014
Q1
$354K Buy
6,536
+754
+13% +$39K 0.22% 93
2013
Q4
$276K Sell
5,782
-374
-6% -$17.1K 0.17% 108
2013
Q3
$280K Hold
6,156
0.19% 100
2013
Q2
$273K Buy
+6,156
New +$275K 0.18% 96

Other funds holding MRK

Montecito Bank & Trust's MRK Position: Q2 2026 in Review

Montecito Bank & Trust reduced its Merck (MRK) stake by 2.1% in Q2 2026, selling an estimated $53.7K and leaving 21,223 shares worth $2.73M. The position accounts for 0.41% of the portfolio, ranked #58.

Montecito Bank & Trust first reported a position in MRK in Q2 2013 and has held it in 46 quarters since. The position peaked at $3.09M in Q3 2024. 1,867 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Montecito Bank & Trust held 21,223 shares of Merck worth $2.73M as of Q2 2026.
  • Montecito Bank & Trust sold 459 Merck shares in Q2 2026, an estimated $53.7K.
  • Merck made up 0.41% of Montecito Bank & Trust's portfolio in Q2 2026, its #58 holding.
  • Montecito Bank & Trust first reported a position in Merck in Q2 2013 and has held it in 46 quarters since.
  • Montecito Bank & Trust's Merck position peaked at $3.09M in Q3 2024.
  • 1,867 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Montecito Bank & Trust's 13F filing for Q2 2026, filed 16 Jul 2026.